Beckman Coulter Diagnostics

Beckman Coulter Diagnostics, established in 1935, is a prominent entity in the clinical diagnostics sector, specializing in the development of advanced products designed to optimize clinical laboratory operations. With a substantial revenue of $2.7B and an employee base exceeding 10,000 individuals across 23 locations, the company demonstrates significant global reach and operational capacity. Its core mission revolves around providing innovative solutions that enhance diagnostic accuracy and efficiency, thereby improving patient care outcomes. The company's extensive history underscores its deep expertise and enduring commitment to scientific advancement within the healthcare industry.

The company's product portfolio encompasses a wide array of clinical diagnostic tools, including immunoassay, hematology, microbiology, and clinical chemistry analyzers, alongside sophisticated information systems and automation solutions. These offerings are crucial for laboratories performing complex testing, from routine blood work to specialized molecular diagnostics. Beckman Coulter Diagnostics is dedicated to empowering laboratory professionals with reliable and high-performance instrumentation and reagents. For insights into the people driving these innovations, you can Meet Beckman Coulter Diagnostics's team to learn more about their leadership and expertise.

Operating within the competitive landscape of Test & Measurement Equipment and Manufacturing, Beckman Coulter Diagnostics faces rivals such as Bio-Rad, Agilent Technologies, and Roche Diagnostics. The company's strategic focus on delivering integrated diagnostic systems and services positions it as a key player in advancing laboratory medicine. Its commitment to scientific rigor and product development ensures it remains at the forefront of diagnostic technology, supporting healthcare providers worldwide in their critical diagnostic endeavors.